The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Intercontinental Exchange Inc.

Related Interviews

Dividend Growth Strategy Favors High-Quality Financials
April 10, 2025
Ellis, Jeremy A.

CoStar vs. Zillow: Both Can Emerge as Winners
February 20, 2025
Campbell, John

Positive Economic Outlook Should Spur Growth in Gaming and Travel
November 22, 2024
Wasiolek, Dan

Investing in Dividend-Paying Small Caps
October 21, 2016
Eagleston, Adam

Outperforming the Market with Less Volatility
September 09, 2016
Abelson, Adam S.

Capital Market-Oriented Financials Face Growth Challenges
March 28, 2016
Rutschow, Rob

Following Global Macro Trends to Discover Attractive Investments
March 14, 2014

A Comparison Between Active and Passive Asset Management
March 08, 2013

Financial Services Rise as U.S. Interest Rates are Expected to Rebound
February 27, 2013

Plays On The Portfolio Re-risking Theme - Michael Kim - Sandler O'neill + Partners, L.p.
March 21, 2011

Investing In Global Value Stocks - Amit Wadhwaney - Third Avenue Management, Llc
February 23, 2009

Andre Durand - Ping Indentity
August 12, 2005

Cart

Latest News

Bear Market Investing: Is There a Way to Profit During Tariff Turmoil?
Tariff Beating US Defense and Aerospace Stocks from Morningstar: “They Don’t Usually Get this Cheap”
Trump Tariff Stock Picks from Award Winning Morgan Stanley Analyst Team

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)

Alan H. Auerbach

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: PBYI

Buy ($25)

Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)

Brian Carrico

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: NRXS

Buy ($25)

Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)

Erez Aminov

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: TELO MIRA

Buy ($25)

Most Popular Reports

Biotechnology, Pharmaceuticals and Medical Devices

Published April 29, 2025

Topics covered: Biotechnology Pharmaceuticals Medical Devices

Buy ($175)

Dividend-Oriented Strategies

Published April 10, 2025

Topics covered: Dividend-Oriented Strategies

Buy ($175)

Industrial Equipment, Aerospace and Defense

Published March 28, 2025

Topics covered: Industrial Equipment, Aerospace and Defense

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)
Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)
Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Asymmetric Risk/Reward at Core of Multi-Asset Strategy
Dividend Growth Strategy Favors High-Quality Financials
Screening for 10% Dividend Growth Over 10 Years
ANALYST INTERVIEWS
Small Cap Med-Tech Names Are More Insulated from Tariff Fallout
Penumbra and AngioDynamics Among Top Med-Tech Sector Picks
Onshoring Drug Manufacturing Is Critical, But Not Easy
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2025
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google